On March 1, 2021 SOM Biotech reported its participation in the BIO-Europe Spring 2021 partnering event on March 22nd – 25th, which will take place digitally due to the pandemic situation (Press release, SOM Biotech, MAR 1, 2021, View Source;utm_medium=rss&utm_campaign=som-biotech-at-bio-europe-spring-2021 [SID1234575861]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Organized by the EBD Group, a global partnering event organizer, the BIO-Europe Spring event attracts leading decision-makers not only from the traditional pharma and biotech sectors but also the world´s most innovative scientific institutions and leading investors in life sciences.

Raúl Insa, CEO of SOM Biotech highlights: "The BIO-Europe is a very relevant global life science partnering event, that enables us to meet with executives of the leading drug development and pharmaceutical industries. Partnering is for SOM Biotech a key strategic pillar and the event offers us a unique opportunity to meet with potential partners to discuss strategic collaborations and share our latest drug development updates. Additionally, the event is a fantastic platform to meet qualified investors, present our strategic growth plan and explore future business opportunities".

Maria Zimina, Business Development Manager of SOM Biotech remarks: "We look forward to meeting with potential partners at BIO-Europe Spring 2021 and continuing building a strong network of pharmaceutical companies and research institutions to boost our development pipeline and strengthen operations with our AI-ligand-based drug discovery technology SOMAIPRO".